Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?
Chronic urticaria is a common disease. Plasmapheresis is an alternative treatment that can be appropriate for patients who are resistant to treatment with 2nd generation antihistamines or for whom treatment with omalizumab is unsuitable.
Main Authors: | Aleksandraviciute Laima, Malinauskiene Laura, Cerniauskas Kestutis, Chomiciene Anzelika |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-12-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2021-0399 |
Similar Items
-
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria
by: Giuseppe Fabio Parisi, et al.
Published: (2018-12-01) -
Treatment of chronic urticaria with omalizumab: the experience of Hospital de Braga
by: Ana G. Lopes, et al.
Published: (2022-10-01) -
Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
by: Elizabeth García-Gómez, et al.
Published: (2022-05-01) -
Chronic urticaria: An overview
by: Yadav Sudha, et al.
Published: (2006-01-01) -
Acute and Chronic Urticaria: Prevalence, Etiologies,
Diagnosis, and Treatment
by: Javad Ghaffari, et al.
Published: (2020-07-01)